139 related articles for article (PubMed ID: 34584697)
21. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
22. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Massive Ovarian Mucinous Cystadenoma With Postmenopausal Bleeding.
Somagutta MR; Luvsannyam E; Jain MS; Elliott-Theberge K; Grewal AS; Pendyala SK; Edwards C
Cureus; 2020 Sep; 12(9):e10198. PubMed ID: 33033676
[TBL] [Abstract][Full Text] [Related]
25. Management of postmenopausal virilization.
Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
[TBL] [Abstract][Full Text] [Related]
26. Benign Ovarian Tumors in Pregnancy: A Case Report of Metachronous Ipsilateral Recurrent Mucinous Cystadenoma in Initial Pregnancy and Mature Cystic Teratoma in Subsequent Pregnancy.
Schreck AM; Mikdachi HF
Cureus; 2019 Jan; 11(1):e3818. PubMed ID: 30868032
[TBL] [Abstract][Full Text] [Related]
27. Telomerase activity in benign and malignant epithelial ovarian tumors.
Wan M; Li WZ; Duggan BD; Felix JC; Zhao Y; Dubeau L
J Natl Cancer Inst; 1997 Mar; 89(6):437-41. PubMed ID: 9091645
[TBL] [Abstract][Full Text] [Related]
28. How hairfall saved the patient from cancer twice - A postmenopausal patient with synchronous endometrial and endocervical carcinomas presenting with endocrine symptoms.
Karangadan S; Nair IR; Menon U; Bhati P; Remadevi C
Post Reprod Health; 2023 Jun; 29(2):109-112. PubMed ID: 37105163
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
30. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
31. Virilization caused by ovarian nodular hyperthecosis in a postmenopausal woman.
Tulandi T; Yu OHY; Boucher LM; Fu L; Arseneau J
CMAJ; 2022 Dec; 194(48):E1647-E1649. PubMed ID: 36511870
[No Abstract] [Full Text] [Related]
32. Extrahepatic biliary cystadenoma with mesenchymal stroma: a true biliary cystadenoma? A case report.
Hennessey DB; Traynor O
J Gastrointestin Liver Dis; 2011 Jun; 20(2):209-11. PubMed ID: 21725521
[TBL] [Abstract][Full Text] [Related]
33. Cell adhesion and apoptosis in ovarian stromal hyperplasia and hyperthecosis.
Sharabidze N; Burkadze G; Sabakhtarashvili M
Georgian Med News; 2006 Feb; (131):33-7. PubMed ID: 16575127
[TBL] [Abstract][Full Text] [Related]
34. Proliferation and apoptosis in ovarian stromal hyperplasia and hyperthecosis.
Sharabidze N; Sabakhtarashvili M; Burkadze G
Georgian Med News; 2005 Dec; (129):26-9. PubMed ID: 16444023
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Cystadenomas: Growth Rate and Reliability of Imaging Measurements.
Suh-Burgmann E; Nakhaei M; Gupta S; Brook A; Hecht J; Hung YY; Levine D
J Ultrasound Med; 2022 Sep; 41(9):2157-2167. PubMed ID: 34846072
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hyperandrogenism of ovarian origin. A clinicopathologic study of four cases.
Honoré LH; Chari R; Mueller HD; Cumming DC; Scott JZ
Gynecol Obstet Invest; 1992; 34(1):52-6. PubMed ID: 1526532
[TBL] [Abstract][Full Text] [Related]
37. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
[TBL] [Abstract][Full Text] [Related]
38. Virilization in pregnancy due to a borderline mucinous ovarian tumor.
Pather S; Atkinson K; Wang I; Russell P; Kesby G; Carter J
J Obstet Gynaecol Res; 2007 Jun; 33(3):384-7. PubMed ID: 17578373
[TBL] [Abstract][Full Text] [Related]
39. Ovarian hyperthecosis: in vivo and in vitro correlations of the androgen profile.
Belisle S; Lehoux JG; Benard B; Ainmelk Y
Obstet Gynecol; 1981 Jun; 57(6 Suppl):70S-5S. PubMed ID: 7243129
[TBL] [Abstract][Full Text] [Related]
40. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report.
Koroscil TM; Harter SB; Ouweleen J; Blauer KL
J Reprod Med; 1996 Apr; 41(4):259-62. PubMed ID: 8728079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
